Combined inhibition of EGFR and c-RAF kinase shows regression of most aggressive panc

[News]

Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National Cancer Research Centre, have published in Cancer Cell the results of a study that shows full regression of advanced pancreatic ductal adenocarcinoma upon combined inhibition of the epidermal growth factor receptor and c-RAF kinase.

More... (https://www.news-medical.net/news/20190412/Combined-inhibition-of-EGFR-and-c-RAF-kinase-shows-regression-of-most-aggressive-pancreatic-cancer.aspx)